Clinical trial
Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple…
NCT00234923 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00234923 |
|---|---|
| Title | Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients |
| Official title | A Pilot, Open-Label, Randomized, Comparative Study of the Antiviral Efficacy of Lopinavir/Ritonavir Single-Drug Regimen Versus Lopinavir/Ritonavir in Combination With Lamivudine/Zidovudine in Antiretroviral Naïve Patients |
| Acronym | MONARK |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | lopinavir/ritonavir, lamivudine/zidovudine |
| Enrollment | 138 |
| Start date | Aug 1, 2003 |
| Primary completion | Feb 1, 2007 |
| First posted | Oct 10, 2005 |
| Last update posted | Apr 3, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: